UPC

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Feb 11, 4:12 PMUniverse Pharmaceuticals announces that its dual-class share structure, with amended charter and new Class A and Class B share capital, will become effective on the Nasdaq Capital Market on February 13, 2026.

Peers: ZTS MRK BIIB REGN VRTX GILD AMGN PFE BMY LLY

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-10.13	Insider Own	1.91%	Shs Outstand	0.56M	Perf Week	-26.13%
Market Cap	1.66M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.55M	Perf Month	-29.50%
Enterprise Value	-22.67M	PEG	-	EPS next Q	-	Inst Own	6.39%	Short Float	2.12%	Perf Quarter	-18.33%
Income	-3.67M	P/S	0.09	EPS this Y	-	Inst Trans	0.03%	Short Ratio	0.13	Perf Half Y	-33.18%
Sales	17.86M	P/B	0.03	EPS next Y	-	ROA	-5.35%	Short Interest	0.01M	Perf YTD	-22.83%
Book/sh	99.64	P/C	0.05	EPS next 5Y	-	ROE	-7.23%	52W High	13.95 -78.93%	Perf Year	-60.16%
Cash/sh	59.61	P/FCF	-	EPS past 3/5Y	82.27% -	ROIC	-6.54%	52W Low	2.51 17.13%	Perf 3Y	-99.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-23.66% -10.27%	Gross Margin	35.28%	Volatility	5.69% 6.76%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-1.27	EPS Y/Y TTM	-100.02%	Oper. Margin	-16.33%	ATR (14)	0.36	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.71	Sales Y/Y TTM	-22.44%	Profit Margin	-20.56%	RSI (14)	29.76	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	4.07	EPS Q/Q	-100.00%	SMA20	-28.71%	Beta	1.53	Target Price	-
Payout	-	Debt/Eq	0.16	Sales Q/Q	-14.14%	SMA50	-28.28%	Rel Volume	0.59	Prev Close	3.62
Employees	216	LT Debt/Eq	0.00	Earnings	-	SMA200	-30.30%	Avg Volume	91.34K	Price	2.94
IPO	Mar 23, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	51,691	Change	-18.78%

Feb-11-26 04:05PM	Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure (GlobeNewswire) -18.78%
Mar-20-25 08:42AM	Universe Pharmaceuticals to conduct share consolidation (SeekingAlpha) -9.18%
08:30AM	Universe Pharmaceuticals INC Announces Share Consolidation (GlobeNewswire)
Feb-25-25 04:10PM	Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report (GlobeNewswire) -6.13%
Feb-03-25 04:10PM	Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request (GlobeNewswire) -35.34%
05:00PM	Loading…
Dec-10-24 05:00PM	Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC) (GlobeNewswire) -15.94% -7.76%
Dec-09-24 07:00AM	Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering (GlobeNewswire) -59.29%
Nov-13-24 08:00AM	Universe Pharmaceuticals INC Announces Share Consolidation (GlobeNewswire) -15.99%
Nov-01-24 04:00PM	Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire) +5.48%
Sep-20-24 04:15PM	Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024 (GlobeNewswire) -13.83% -13.95%
Sep-19-24 12:39PM	Fall Trends in Shareholder Activism: Vinson & Elkins Partner Patrick Gadson, Live from NYSE (CorpGov.com)
Jul-15-24 07:35AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +6.97%
Jul-03-24 07:21AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +8.28%
Feb-20-24 08:32AM	Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today? (InvestorPlace) -28.46%
Jan-30-24 04:30PM	Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results (PR Newswire) -14.64%
08:30AM	Loading…
Aug-04-23 08:30AM	Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares (GlobeNewswire) -6.83%
Jul-27-23 10:15AM	Universe Pharmaceuticals INC Announces Share Consolidation (GlobeNewswire) +6.33%
Mar-07-23 08:00AM	Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Dec-21-22 08:00AM	Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (GlobeNewswire)
Nov-14-22 08:00AM	Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Aug-16-22 08:00AM	Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022 (PR Newswire)
Jul-19-22 06:00AM	Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Mar-30-22 08:00AM	Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms (GlobeNewswire)
Mar-22-22 08:00AM	Universe Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research Center (GlobeNewswire)
Feb-09-22 11:18AM	Universe Pharmaceuticals INC's (NASDAQ:UPC) Earnings Are Not Doing Enough For Some Investors (Simply Wall St.)
Jan-31-22 08:00AM	Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial Results (GlobeNewswire)
Jan-04-22 08:00AM	Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine (GlobeNewswire) -5.62%
Dec-29-21 08:00AM	Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine (GlobeNewswire)
Dec-15-21 04:30PM	Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer (GlobeNewswire)
Dec-13-21 08:30AM	Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine (GlobeNewswire)
08:00AM	Loading…
Aug-02-21 08:00AM	Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2021 (GlobeNewswire) +9.28%
Jul-30-21 08:00AM	Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021 (GlobeNewswire)
Jul-26-21 08:00AM	Universe Pharmaceuticals INC Hosts Reception for Member of Chinese Academy of Engineering and Expert Group from Tianjin University of Traditional Chinese Medicine (GlobeNewswire) -8.22%
Jun-24-21 09:00AM	Should You Be Impressed By Universe Pharmaceuticals INC's (NASDAQ:UPC) ROE? (Simply Wall St.)
May-25-21 08:00AM	Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd. (GlobeNewswire)
May-12-21 08:00AM	Universe Pharmaceuticals INC Attends West Lake Forum and Exhibits Upgraded Products (GlobeNewswire)
Mar-31-21 04:30PM	Univest Securities, LLC Announces the Full Exercise of Underwriters Over-Allotment Option for its Client Universe Pharmaceuticals INC in the Public Offering (Nasdaq: UPC) (GlobeNewswire) -8.24% +30.92%
04:15PM	Universe Pharmaceuticals INC Announces Full Exercise of Underwriters Over-Allotment Option in the Public Offering (GlobeNewswire)
Mar-29-21 12:25PM	Analyzing The Price Action In Universe Pharmaceuticals Stock Today (Benzinga) +38.18%
Mar-25-21 04:30PM	Univest Securities, LLC Announces Closing of IPO for its Client Universe Pharmaceuticals INC (Nasdaq: UPC) (GlobeNewswire)
04:20PM	Universe Pharmaceuticals INC Announces Closing of Initial Public Offering (GlobeNewswire)
Mar-23-21 08:50AM	Universe Pharmaceuticals INC Announces Pricing and Trading of Initial Public Offering (GlobeNewswire)

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Universe Pharmaceuticals INC

Upgrade your FINVIZ experience